• MILIND J. AMIN K. B. Raval College of Pharmacy, Shertha, Gandhinagar 382423, Gujarat, India
  • KEYUR S. PATEL Kalol Institute of Pharmacy, Kalol, Gandhinagar 382721, Gujarat, India
  • DEEPA R. PATEL Kalol Institute of Pharmacy, Kalol, Gandhinagar 382721, Gujarat, India
  • ZIL P. PATEL Kalol Institute of Pharmacy, Kalol, Gandhinagar 382721, Gujarat, India
  • JAYANTI V. BAJAG School of Pharmacy, Rai University, Dholka, Ahmedabad 382260, Gujarat, India



Lornoxicam, Sustained release pellets, Eudragit, RLPO, Eudragit RSPO


Objective: The aim of the study was to develop sustained release pellets of lornoxicam using Eudragit RLPO and Eudragit RSPO to reduce the dosing frequency.

Methods: The sustained release pellets of lornoxicam were prepared by extrusion–spheronization technique using Eudragit RLPO and Eudragit RSPO as release retardant polymers and microcrystalline cellulose as spheronizing agent. A 32 Full factorial design was applied to investigate the combined effect of the two independent variables i.e. concentration of Eudragit RLPO (X1) and concentration of Eudragit RSPO (X2) on the dependent variables, In vitro drug release at 1h (Y1), In vitro drug release at 4 h (Y2) and In vitro drug release at 12 h. (Y3).

Results: The optimized formulation (F0) show in vitro drug release 11.24±1.21 %, 43.69±1.28 %, 82.69±1.74 % and 100.24±1.56 % at 1 h, 4 h, 12 h and 24 h respectively. Drug excipients compatibility study by FTIR showed no interaction between drug and excipients. Eudragit RLPO and Eudragit RSPO had a significant effect on in vitro drug release.

Conclusion: From all parameters and experimental design evaluation, it was concluded that the drug release rate decreased with an increase the concentration of Eudragit RLPO and Eudragit RSPO. SEM Photomicrograph of pellets revealed that the surface was rough and the pellets were spherical shaped in nature. The in vitro release kinetics revealed higuchi model is followed and drug release is by anamolous diffusion.


Download data is not yet available.


Raman SK, Suggula SR, Yakkala AR. Formulation and in vitro characterization of aceclofenac sustained-release pellets prepared by suspension layering technique using sugar spheres. Int J Drug Delivery 2014;6:292-300.

Shanteer VS, Lingaraj SD. Preparation and evaluation of sustained release matrix tablets of propranolol hydrochloride. Int J Pharm Bio Sci 2010;1:227-41.

Tripura S, Gaud R. Formulation and evaluation of alcohol resistant dosage forms of diclofenac sodium. Int J Pharm Pharm Sci 2013;5:854–85.

Patel S, Patel M. Formulation and evaluation of sustained release pellets of tramadol hcl using 32 full factorial design. Int J PharmTech Res 2014;6:1736-45.

Manivannan R, Parthiban KG, Sandeep G, Balasubramanium A, Senthikumar N. Multiparticulate drug delivery systems: pellet and pelletization technique. Drug Invention Today 2010;2:233-7.

Saki S, Ishtiaq A, Muhammad RI, Habibur R. Development of salbutamol sulphate sustained-release pellets using acrylic polymer and polyvinyl acetate polymer and evaluation of in vitro release kinetics. J Pharm Sci 2010;9:109-18.

Kristensen HG, Schaefer T. Granulation. A review of pharmaceutical wet granulation. Drug Dev Ind Pharm 1987;13:803-72.

Ghebre SI. Pellets. A general overview. Pharmaceutical pelletization technology. I. (ed). Marcel Dekker Inc: New York, USA; 1989;37:1-13.

Siepmann F, Siepmann J, Walther M, Macrae RJ, Bodmeire R. Blends of aqueous polymer dispersions used for pellet coating: Importance of the particle size. J Controlled Release 2005;105:226-39.

Pandit AP, Shinde RD. Development and in vitro evaluation of sustained release multiparticulate tablet of freely water-soluble drug. Braz J Pharm Sci 2010;46:463-71.

Evdokia D. Optimization of the pelletization process in a fluid bed rotor granulator using experimental design. AAPS PharmSciTech 2000;35:1-4.

Homdrum EM, Likar R, Nell G. Rapid: a novel effective tool for pain treatment. Eur Surg 2006;38:342–52.

Yassin El-SH, Mona HA. Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination. AAPS PharmSciTech 2009;10:1357-67.

Kidd B, Frenzel W. A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis. J Rheumatol 1996;23:1605–11.

Songa AS, Meka VS, Rao NS, Sakamuri B, Kolapalli VR. Design and evaluation of lornoxicam bilayered tablets for biphasic release. Braz J Pharm Sci 2012;48:609-19

Chandarana DA, Patel KS, Patel SC, Patel DR, Prajapati ST. Formulation and evaluation of mucoadhesive buccal tablets of carvedilol. Int J Appl Pharm 2020;12:170-81.

Madat DV, Gohel MC. Statistical optimization of venlafaxine hydrochloride controlled-release pellets prepared employing the blend of ethyl cellulose and HPMC. J Pharm Res 2011;4:607-9.

Sain JP, Patel KS, Patel SC, Patel DR. Formulation and evaluation of gastroretentive floating pellets of nizatidine. Asian J Pharm 2020;14:513-24.

Han X, Wang L, Sun Y, Liu X, Liu W, Du Y, et al. Preparation and evaluation of sustained-release diltiazem hydrochloride pellets. AJPS 2013;8:244-51.

Jadhav N, Gade M, Salunkhe N, Paradkar A. Extrusion-spheronization of talc using microcrystalline cellulose as a pellet aid: Part I. J Pharm Innov 2014;9:321-30.

Gupta V, Gowda D, Balamuralidhara V, Khan S. Formulation and evaluation of olanzapine matrix pellets for controlled release. DARU 2011;19:32-42.

Gawale D, Sonawane RO, Pandey VV Pradum P. Formulation and in vitro characterization of multiple unit sustained release matrix pellets of lornoxicam using natural gums. Indian J Novel Drug Delivery 2013;5:208-20.

Nath B, Nath LK, Kumar P. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations. Acta Poloniae Pharm Drug Res 2011;68:409-15.

Patel KS, Patel MB. Formulation and evaluation of eudragit microspheres containing nicorandil. Int J Pharm Res Sch 2014;3:35-40.

Kothiya OM, Patel BA, Patel KN, Patel MM. Formulation and characterization of sustained release matrix tablets of ivabradine using 32 full factorial designs. Int J Appl Pharm 2018;10:59-66.

Deshkar S, Satpute A. Formulation and optimization of curcumin solid dispersion pellets for improved solubility. Int J Appl Pharm 2020;12:36-46.



How to Cite

AMIN, M. J., PATEL, K. S., PATEL, D. R., PATEL, Z. P., & BAJAG, J. V. (2021). FORMULATION AND EVALUATION OF SUSTAINED-RELEASE PELLETS OF LORNOXICAM. International Journal of Applied Pharmaceutics, 13(4), 221–227.



Original Article(s)

Most read articles by the same author(s)